NasdaqCM - Nasdaq Real Time Price USD
BioLife Solutions, Inc. (BLFS)
22.03
-1.27
(-5.45%)
At close: June 13 at 4:00:01 PM EDT
22.03
0.00
(0.00%)
After hours: June 13 at 4:45:18 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -0.01 | -0 | 0.02 | 0.16 |
| Low Estimate | -0.02 | -0.02 | -0.05 | 0.1 |
| High Estimate | 0.02 | 0.02 | 0.1 | 0.2 |
| Year Ago EPS | -0.05 | -0.02 | -0.06 | 0.02 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 8 |
| Avg. Estimate | 23.71M | 24.56M | 97.75M | 114.93M |
| Low Estimate | 22.8M | 24.2M | 97.2M | 112M |
| High Estimate | 24.42M | 24.91M | 98.67M | 120.4M |
| Year Ago Sales | 28.33M | 30.57M | 82.25M | 97.75M |
| Sales Growth (year/est) | -16.30% | -19.66% | 18.84% | 17.57% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.09 | -0.05 | -0.06 | -0.04 |
| EPS Actual | -0.05 | -0.02 | -0.02 | 0.04 |
| Difference | 0.04 | 0.03 | 0.04 | 0.07 |
| Surprise % | 45.68% | 62.50% | 71.77% | 201.43% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.01 | -0 | 0.02 | 0.16 |
| 7 Days Ago | -0.01 | -0 | 0.02 | 0.16 |
| 30 Days Ago | -0.01 | -0 | 0.02 | 0.16 |
| 60 Days Ago | -0.01 | 0 | -0.03 | 0.15 |
| 90 Days Ago | -0.01 | 0 | -0.03 | 0.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 3 | 1 |
| Up Last 30 Days | 2 | 2 | 3 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BLFS | 85.21% | 71.43% | 130.96% | 716.65% |
| S&P 500 | 13.13% | 2.41% | 7.55% | 14.06% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/6/2025 |
| Maintains | Northland Capital Markets: Outperform to Outperform | 1/8/2025 |
| Reiterates | Benchmark: Buy to Buy | 12/19/2024 |
| Maintains | Keybanc: Overweight to Overweight | 12/13/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/18/2024 |
Related Tickers
ATRC AtriCure, Inc.
31.62
-2.20%
1SXP.F SCHOTT Pharma AG & Co. KGaA
30.05
+0.17%
1SRT.MI Sartorius Aktiengesellschaft
168.20
0.00%
GXI.F Gerresheimer AG
47.08
-1.47%
ADDV-B.ST ADDvise Group AB (publ)
1.6900
-3.10%
STVN Stevanato Group S.p.A.
23.48
-2.17%
DIM.PA Sartorius Stedim Biotech S.A.
199.05
-1.95%
INFU InfuSystem Holdings, Inc.
6.21
+1.80%
RGEN Repligen Corporation
127.52
-2.88%
NVST Envista Holdings Corporation
18.45
-2.23%